Sandra Kim, MD is medical director of the nationally recognized Inflammatory Bowel Disease (IBD) Center, within the Division of Gastroenterology, Hepatology and Nutrition. She is an associate professor of clinical pediatrics at the Ohio State University College of Medicine. Dr. Kim’s clinical and research interests focus on pediatric inflammatory bowel diseases, including adolescent transitioning and quality improvement in pediatric IBD and the impact of the gastrointestinal microbiota in IBD. Her research has been funded by the NIH and the Crohn’s and Colitis Foundation of America (CCFA). Dr. Kim currently serves as Chair of Pediatric Affairs for CCFA nationally and is a member of the Executive Committee for the CCFA National Scientific Advisory Committee (NSAC) as well as the steering committee for the CCFA Pediatric IBD Research Network (PRO-KIIDS). In addition, she chairs the Clinical Practice and Adolescent Transitioning committees and serves on the Physician Leadership committee for ImproveCareNow, a national, multi-institution collaborative focusing on improving outcomes in IBD patients. Dr. Kim also is involved as a member of the Medical advisory Board for Flying Horse Farms and involved in the leadership for the Central Ohio CCFA CMAC. As a reflection of her dedication to her profession, Dr. Kim was awarded the 2011 Rosenthal Award for her leadership in patient education and advocacy by the CCFA. She has also authored numerous studies on pediatric and adolescent inflammatory bowel diseases.
Learn more about Sandra Kim, MD, medical director of our nationally recognized Inflammatory Bowel Disease (IBD) Center.